Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-005828

Chief Executive Officer bought 2,750 shares at $1.80 ($4,945)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-16 Purchase : show line 1 in the form +2,750 $1.80 $4,945 49,010 D
Open-market purchases · 2,750 sh · avg $1.80 · $4,945
Loading xslF345X05/ownership.xml…